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New biphenyl iminium salt catalysts for highly
enantioselective asymmetric epoxidation: role of
additional substitution and dihedral angle†
Philip C. Bulman Page,*a Christopher J. Bartlett,a Yohan Chan,a Steven M. Allin,b
Michael J. McKenzie,c Jérôme Lacourd and Garth A. Jonesa
New biaryl iminium salt catalysts for enantioselective alkene epoxidation containing additional substitution
in the heterocyclic ring are reported. The eﬀects upon conformation and enantioselectivity of this
additional substitution, and the inﬂuence of dihedral angle in these systems, has been investigated using a
synthetic approach supported by density functional theory. Enantioselectivities of up to 97% ee were
observed.
Introduction
Asymmetric epoxidation of alkenes to generate non-racemic
chiral epoxides is an extremely powerful synthetic tool,1 and
the development of eﬀective organocatalytic systems for epoxi-
dation has received considerable attention.2 The most success-
ful organocatalytic methods for epoxidation are those utilizing
dioxiranes and those utilizing oxaziridinium salts. Chiral
ketones used as precursors to dioxiranes, such as those of
Yang,3 Denmark,4 Armstrong,5 and especially Shi,6 have
achieved high enantioselectivities, with observed enantiomeric
excesses exceeding 97% in the best cases. Oxaziridinium salts,
first reported by Lusinchi in 1976,7 are also reactive reagents
for oxygen transfer to nucleophilic substrates such as sulfides
and alkenes, and may be generated catalytically by use of
iminium salts in the presence of a stoicheiometric oxidant,
typically Oxone.8 We have developed a range of catalysts based
on biphenylazepinium (e.g. 1), binaphthylazepinium (e.g. 2)
and dihydroisoquinolinium (e.g. 3) moieties containing a
chiral appendage on the nitrogen atom for epoxidation reac-
tions, with the most successful to date containing the 1,3-
dioxane motif of (S,S)-acetonamine 4 (Fig. 1).9 We have also
shown that alternative oxidants may be used in iminium salt-
catalysed epoxidation reactions such as hydrogen peroxide,10
sodium hypochlorite,11 and electrochemically-generated oxi-
dants.12 Amines have also been used as iminium precursors in
related epoxidation processes by us13 and others.14
We reported the first very high enantioselectivities in the
asymmetric epoxidation of alkenes using iminium salt cata-
lysts, and we have developed non-aqueous conditions for these
processes using tetraphenylphosphonium monoperoxysulfate
(TPPP)15 as the oxidant.16 We have used the process in the
syntheses of levcromakalim,17 (−)-lomatin, (+)-trans-khellac-
tone,18 and scuteflorin19 utilizing catalysts 1 and 3.
We have shown that incorporation of a pseudo-axial substi-
tuent at the prochiral carbon atom α- to the nitrogen atom in
biaryl systems 1 and 2 aﬀords higher enantioselectivities, with
the addition of a methyl group found to have the greatest influ-
ence.20 It has also been reported that the level of enantiocon-
trol imparted by biaryl azepinium salt catalysts in the
epoxidation of alkenes is in part correlated with the dihedral
angle around the biphenyl axis in the iminium species,21
suggesting a parallel pattern of dihedral angles between the
iminium parents and the putative derived oxaziridinium oxi-
dative intermediates. It was further suggested that this angle is
both larger and nearer to the optimum in the octahydrobi-
naphthyl series than in the parent binaphthyl series.
Fig. 1 Iminium salt catalysts.
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We were interested to investigate this potential correlation
between dihedral angles in the iminium species and in the
oxaziridinium oxidative intermediates, and if any correlation
might also be observed between dihedral angles and induced
enantioselectivities. Consequently, geometry optimizations
were carried out on oxaziridinium intermediates, as well as the
iminium species, at the B3LYP/6-31G* level of theory. These
calculations indeed suggest that there is little change in di-
hedral angles between the iminium and oxaziridinium species
in the lowest energy conformations (vide infra).
We were interested to learn if related structural modifi-
cations would also improve the enantioselectivity of our other
biaryl-containing catalysts. We report herein the design and
use of new iminium salt catalysts combining both of these
modifications (Fig. 2).
Results and discussion
Synthesis
To begin with, we focused on synthesis of the simpler 6,6′-di-
methylbiphenyl backbone, with iminium salts 5Rax, 5Sax and
6Rax, 6Sax as targets. The synthesis of racemic bis-carboxalde-
hyde (±)-7 was achieved following literature procedures.21,22
Formation of the diazonium salt from 3-methylanthranilic
acid followed by coupling of the radical generated in situ gave
bis-acid (±)-8 in 58% yield. High concentration of the diazo-
nium salt and careful temperature control are key factors to
obtain an acceptable yield of (±)-8, as formation of the corres-
ponding diazo compound, a bright yellow solid, competes
with the desired reaction. We first used the racemic bis-acid,
ultimately to access both diastereoisomers 5Rax and 5Sax in
order to assess separately their potential as catalysts, in the
expectation of finding ‘matched’ and ‘mismatched’ systems,
and reasoning that separation of the diastereoisomers would
be more practical on suﬃcient scale than resolution of the bis-
acid. Reduction of (±)-8 to the diol (±)-9 with lithium alu-
minium hydride proceeded in 96% yield. Oxidation of the two
alcohol moieties of (±)-9 using PCC yielded the desired bis-car-
boxaldehyde (±)-7 in 87% yield. Reductive cycloamination of
(±)-7 with enantiomerically pure (S,S)-acetonamine 4 gave dia-
stereoisomers 10Rax, 10Sax, which were separated using silica
gel column chromatography, in 49% and 26% yields respect-
ively (Scheme 1).
Resolution of bis-acid (±)-8 using quinine following a litera-
ture procedure provided us with the means to prepare a single
diastereoisomer of 10.22 By comparison of spectroscopic data
and optical rotation, the amine diastereoisomer obtained from
(+)-8Sax was found to be identical to 10Sax, allowing us to attri-
bute the absolute configurations of 10Rax and 10Sax.
Oxidation of 10Rax, 10Sax separately using NBS followed by
counter-ion exchange gave the corresponding tetraphenylbo-
rate iminium salts 5Rax and 5Sax in 61% and 83% yields
respectively. Diastereoselective addition of methyl magnesium
bromide gave 11Rax and 11Sax as single diastereoisomers, the
methyl groups being introduced into a pseudo-axial position
in each case, as we have previously observed,20 controlled by
the axial chirality of the biphenyl backbone, and appearing in
the 1H NMR spectra at high field (11Rax: 0.21 ppm; 11Sax:
0.14 ppm).
Oxidation of 11Rax, 11Sax and anion exchange gave
α-methylated iminium salts 6Rax, 6Sax as single diastereo- and
regio-isomers in 28% and 32% yields over the three steps,
respectively (Scheme 2), resulting from loss of the more acces-
sible single remaining axial hydrogen atom in each case.20,23
Scheme 1 Synthesis of 6,6’-dimethylbiphenyl azepines. Reagents and
conditions: (i) HCl, NaNO2; then Cu2SO4, (NH4OH)2·H2SO4, NH4OH,
<5 °C, 58%; (ii) LiAlH4 (3 equiv.), Et2O, r.t., 96%; (iii) PCC (3 equiv.),
CH2Cl2, r.t., 87%, (iv) Amine 4 (1 equiv.), NaBH3CN (2.2 equiv.), MeOH,
AcOH, r.t., 24 h, [10Rax, 49%] and [10Sax, 26%]; (v) quinine, EtOH (90%),
crystallization then (b) 3 M HCl, 70%.
Scheme 2 Synthesis of 6,6’-dimethylbiphenyl catalysts. Reagents and
conditions: (i) NBS (1.1 equiv.), CH2Cl2, 0 °C then reﬂux, 2 h, then
NaBPh4, EtOH, 5 min; (ii) MeMgBr (10 equiv.), THF, −78 °C to r.t.; (iii) NBS
(1.1 equiv.), CH2Cl2, 0 °C then reﬂux, 2 h, then NaBPh4, EtOH, 5 min.
Fig. 2 New biaryl catalysts.
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem., 2016, 14, 4220–4232 | 4221
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
6 
M
ar
ch
 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
1/
02
/2
01
7 
08
:3
8:
54
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
The yield of the oxidation step was moderated by competing
bromination of the methyl groups at the 6,6′ positions.
We next turned our attention to the preparation of similar
catalysts using the octahydrobinaphthyl backbone, where the
iminium salt possesses large dihedral angles.21 Octahydrobi-
naphthyl-2,2′-bis-methanol 12 was obtained following litera-
ture procedures (Scheme 3).21,24 (R)-Binol was hydrogenated to
(R)-octahydrobinol 13 using palladium on carbon under hydro-
gen pressure in 45% yield. Triflation of the phenolic hydroxyl
moieties to give 14, followed by palladium-catalysed carbonyla-
tion to give 15,25 and reduction using lithium aluminium
hydride gave (R)-octahydrobinaphthyl-1,1′-methanol 12 in 83%
yield over the three steps.
Compound 12 was converted into the corresponding (R)-
bis-carboxaldehyde 16 in quantitative yield. Tertiary amine 17
was, however, only obtained in 67% yield using the reductive
cycloamination protocol. An alternative procedure consisting
of displacing two bromide ions using (S,S)-acetonamine 4 was
therefore used. Diol 12 was successfully bis-brominated to give
18 using phosphorus tribromide in 90% yield; double displace-
ment with (S,S)-acetonamine 4 gave the desired amine 17 in
an excellent 97% yield (Scheme 4).
Amine 17 was oxidized using NBS to aﬀord iminium salt 19
in 73% yield. The corresponding α-methylated azepinium salt
was obtained through a similar sequence to that described
above, involving diastereoselective Grignard reagent addition
to give 20 followed by oxidation and anion exchange to give 21
in 56% yield over the two steps. Again, the α-methylated
iminium salt 21 was obtained as a single regio- and diastereo-
isomer with a pseudo-axial methyl group (Scheme 5).20
Calculations
Geometry optimizations were carried out on a range of these
iminium species and their putative derived oxaziridinium
ions, at the B3LYP/6-31G* level using Gaussian 09,26 to deter-
mine the dihedral angles ϕ and θ in the lowest energy confor-
mations. Both possible diastereoisomers were investigated in
the case of each oxaziridinium ion. All stationary point struc-
tures were characterized by harmonic frequency analysis, and
shown to be genuine energy minima (Tables 1 and 2). Carte-
sian co-ordinates of the optimized structures can be found in
ESI.†
For the oxaziridinium ions (Table 1), the calculations
demonstrate a clear increase in dihedral angles upon moving
from the biphenyl species (around 38–42°) to the 6,6′-di-
methylbiphenyl (around 54–58°) and the octahydrobinaphthyl
(around 55–64°) species. Larger dihedral angles were also
observed as expected in the binaphthyl species (around
54–59°).
It is interesting to note that the pair of diastereoisomeric
oxaziridinium ions in each case display similar dihedral
angles, with the diﬀerences varying from 0.3° to 6.8° for ϕ and
0.1° to 3.7° for θ, the larger figures being observed for the octa-
hydro species. Similar calculations carried out on the derived
iminium ions suggest that similar dihedral angles also obtain
for the iminium and derived oxaziridinium species; the calcu-
lations suggest that the dihedral angles diﬀer by no more than
6.3° from those of the corresponding iminium species.
Incorporation of a methyl substituent at the prochiral
carbon atom α- to the nitrogen atom in the heterocyclic ring
does not, however, greatly aﬀect the dihedral angles for either
Scheme 5 Synthesis of octahydrobinaphthyl catalysts. Reagents and
conditions: (i) NBS (1.1 equiv.), CH2Cl2, r.t., 30 min then NaBPh4, EtOH,
73%; (ii) MeMgBr (10 equiv.), THF, −78 °C to r.t., 16 h, 79%; (iii) NBS (1.1
equiv.), CH2Cl2, r.t., 30 min then NaBPh4, EtOH, 71%.
Scheme 3 Synthesis of octahydrobinol derivatives. Reagents and con-
ditions: (i) Pd/C, H2 (3.5 bar), AcOH, 80 °C, 10 d, 45%; (ii) Tf2O (3 equiv.),
DMAP (0.4 equiv.), 2,6-lutidine (3 equiv.), −30 °C to r.t., 16 h, 99%; (iii)
Pd(OAc)2 (0.15 equiv.), dppp (0.15 equiv.), MeOH (50 equiv.), DMSO,
DIPEA, CO (2 bar), 80 °C, 48 h, 85%; (iv) LiAlH4 (2 equiv.), Et2O, 99%.
Scheme 4 Synthesis of octahydrobinaphthyl azepine. Reagents and
conditions: (i) PCC (1 equiv.), CH2Cl2, r.t., 2 h, 99%; (ii) 4 (1 equiv.),
NaBH3CN (2.2 equiv.), AcOH, r.t., 24 h, 67%; (iii) PBr3 (3 equiv.), pyridine
(0.1 equiv.), toluene, 60 °C, 3 h, 90%; (iv) Amine 4 (1 equiv.), K2CO3
(3 equiv.), MeCN, reﬂux, 16 h, 97%.
Paper Organic & Biomolecular Chemistry
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the iminium or oxaziridinium species (no more than about
2°). In the biphenyl cases 22 and 23, and the precursor
iminium species 1 and 30, where interconversion between the
atropoisomers is readily possible, the S,S-acetonamine unit
induces a preference for the R-axial chirality in the biaryl unit.
The methyl substituents in 23 and 30 occupy pseudo-axial
positions, as is observed in the other methyl-substituted
examples.
Epoxidation reactions
Iminium salts 5Rax, 5Sax, 6Rax, 6Sax, 19, and 21 were used in
the asymmetric epoxidation of a number of alkenes under
optimized reaction conditions,27 and the results compared
with known results from species 1 and 30 (Table 3).20 We have
previously observed that the related binaphthyl catalysts 2 and
31 display somewhat diﬀerent profiles of reactivity and selecti-
vity from those of the biphenyl series,9a,20 and these catalysts
are therefore not included in this analysis.
Aqueous conditions using Oxone as oxidant and a mixture
of acetonitrile and water as solvent gave the highest reactivities
and enantioselectivities. Non-aqueous conditions using TPPP
as oxidant and acetonitrile as solvent were less successful,
however; for example, use of chloroform as solvent gave an ee
lower than 5%. The enantioselectivity observed when
18-crown-6 and a biphasic system28 were used was also poor.
Table 1 Dihedral angles calculated for oxaziridinium species
Structure ϕ/θ Structure ϕ/θ
ϕ = −40.1 ϕ = −37.9
θ = −41.3 θ = −40.4
ϕ = 38.9 ϕ = 39.4
θ = 41.7 θ = 40.8
ϕ = −38.7 ϕ = −37.7
θ = −39.2 θ = −39.7
ϕ = −58.5 ϕ = −56.4
θ = −54.8 θ = −54.0
ϕ = −58.1 ϕ = −56.0
θ = −54.0 θ = −53.9
ϕ = −57.8 ϕ = −56.3
θ = −54.7 θ = −54.4
ϕ = 56.3 ϕ = 57.5
θ = 55.0 θ = 54.7
ϕ = −57.7 ϕ = −55.6
θ = −53.9 θ = −54.3
ϕ = 57.2 ϕ = 57.5
θ = 54.9 θ = 54.3
ϕ = −63.0 ϕ = −57.3
θ = −58.3 θ = −54.6
ϕ = −63.8 ϕ = −57.0
θ = −57.6 θ = −54.9
Table 2 Dihedral angles calculated for iminium species
Structure ϕ/θ Structure ϕ/θ
ϕ = −34.9 ϕ = −33.8
θ = −39.6 θ = −37.6
ϕ = −52.2 ϕ = −52.2
θ = −53.0 θ = −52.2
ϕ = −53.1 ϕ = −52.7
θ = −53.7 θ = −52.5
ϕ = 52.4 ϕ = 52.7
θ = 53.7 θ = 53.3
ϕ = −59.7 ϕ = −60.0
θ = −58.0 θ = −57.3
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From our results, it appears that observed enantioselectivi-
ties indeed increase for the trisubstituted alkenes from
37–60% ee for the simple biphenyl catalyst 1 (78–82% ee for
the methylated derivative 30), with dihedral angles around
34–40°, to 60–93% ee for the matched 6,6′-dimethylbiphenyl
catalyst 5R, with dihedral angles around 52–54°, and the octa-
hydro binaphthyl catalyst 19, with dihedral angles around
57–60° (69–97% ee for the methylated derivatives 6R and 21
respectively).
For catalysts 5 and 6, the ‘matched’ diastereoisomers, indu-
cing higher enantioselectivities, are the (Rax) 5Rax and 6Rax,
and the ‘mismatched’ ones are the (Sax) 5Sax and 6Sax, which
are also generally less reactive. It is interesting to note that the
relative stereochemistry of diastereoisomers 5Rax and 6Rax
corresponds to that seen in the lowest energy atropoisomer of
the simple biphenyl analogue 1.
While the incorporation of a methyl substituent α to the
nitrogen atom generally increases the enantiocontrol, it has a
detrimental or no eﬀect on the mismatched diastereoisomers
5Sax and 6Sax. The sense of stereochemical induction in the
epoxidation process is controlled by the configuration of the
biaryl backbone. Catalyst 6Rax, with the added methyl group, is
in most cases superior to catalyst 5Rax. The octahydrobi-
naphthyl catalyst 21, with an additional methyl group, pro-
vides the highest enantioselectivities that we have seen for the
epoxidation of 1-phenylcyclohexene, at 96% ee, and for
1-phenyl dihydronaphthalene, at 97% ee.
Conclusions
The results described herein provide further evidence that
addition of additional methyl substituents adjacent to the
nitrogen atom in the heterocyclic ring can provide improve-
ments in enantioselectivities in catalysed epoxidation reac-
tions, with the α-methylated octahydrobinaphthyl catalyst 21
giving the best results of this series; particularly noteworthy
are the epoxidations of 1-phenylcyclohexene, at 96% ee, and of
1-phenyl dihydronaphthalene, at 97% ee.
Calculations clearly suggest a parallel pattern of dihedral
angles between the iminium parents and the putative derived
oxaziridinium oxidative intermediates.
Experimental results also support the conjecture that some
correlation may be observed between the dihedral angle found
in the biaryl units of these iminium salt catalysts and the
induced enantioselectivities in the catalysed epoxidation reac-
tions. The 6,6′-dimethylbiphenyl catalysts 5 and 6 (dihedral
angles around 52–54°) are superior to the simpler biphenyl
species 1 and 30 (dihedral angles around 34–40°). The octahy-
drobinaphthyl catalysts 19 and 21 (dihedral angles around
57–60°) induce generally similar enantioselectivities to the
6,6′-dimethylbiphenyl species, perhaps suggesting optimum
dihedral angles of around 50–60° as one factor in the induc-
tion of enantioselectivities in the catalysed epoxidation
reactions.
Experimental section
General procedure for the addition of methyl Grignard reagent
to iminium salts
The iminium salt was dissolved in Et2O (50 mL per g of
iminium salt) under an atmosphere of N2. The solution was
cooled to −78 °C. A 3 molar solution of MeMgCl in THF (10
equiv.) was added dropwise over 10 min. After 1 h, cooling was
ceased, and the mixture allowed to reach ambient temperature
overnight. Saturated aqueous NH4Cl (5 mL per g of iminium
salt) and CH2Cl2 (30 mL per g of iminium salt) were added.
The resulting mixture was transferred to a separating funnel,
and brine (100 mL) added. The organic layer was collected and
the aqueous layer washed with CH2Cl2 (2 × 50 mL per g of
iminium salt). The combined organic layers were washed with
Table 3 Asymmetric epoxidation mediated by iminium salts 1, 5, 7a–b,
8a–b, 9, 10
Substrate Cat. Time Conv.b/% eec/% Config.d
1a 5 min 100 60e (−)-(1S,2S)
30a 0.5 h 100 82e (−)-(1S,2S)
5Rax 0.8 h 99 87
e (−)-(1S,2S)
6Rax 1 h 99 92
e (−)-(1S,2S)
5Sax 1.8 h 99 82
e (+)-(1R,2R)
6Sax 3 h 99 82
e (+)-(1R,2R)
19 0.6 h 99 90 f (−)-(1S,2S)
19a 1 h 99 80 f (−)-(1S,2S)
21a 1.5 h 99 96 f (−)-(1S,2S)
1a 3 min 90 41 (+)-(1R,2S)
30a 0.5 h 100 78 (+)-(1R,2S)
5Rax 0.5 h 99 89 (+)-(1R,2S)
5Rax
a 0.3 h 98 81 (+)-(1R,2S)
6Rax 1 h 99 85 (+)-(1R,2S)
5Sax 2 h 99 82 (−)-(1S,2R)
6Sax 6 h 77 78 (−)-(1S,2R)
19 0.7 h 99 93 (+)-(1R,2S)
19a 1.3 h 99 86 (+)-(1R,2S)
21a 3 h 87 97 (+)-(1R,2S)
1a 5 min 95 37 (−)-(1S,2S)
5Rax 3 h 99 67 (−)-(1S,2S)
6Rax 3 h 99 73 (−)-(1S,2S)
5Sax 6 h 99 60 (+)-(1R,2R)
6Sax 6 h 99 48 (+)-(1R,2R)
19 1 h 99 60 (−)-(1S,2S)
19a 2 h 99 63 (−)-(1S,2S)
21a 18 h 80 69 (−)-(1S,2S)
1a 5 min 95 5 (−)-(1S,2S)
5Rax 4.3 h 99 15 (−)-(1S,2S)
6Rax 6 h 99 39 (−)-(1S,2S)
5Sax 6 h 99 8 (+)-(1R,2R)
6Sax 6 h 99 10 (+)-(1R,2R)
Conditions: oxone® (2 equiv.), NaHCO3 (5 equiv.), catalyst (5 mol%),
MeCN : H2O 10 : 1, 0 °C.
a Conditions: oxone® (2 equiv.), NaHCO3 (5
equiv.), catalyst (5 mol%), MeCN : H2O 1 : 1, 0 °C.
b Conversions were
evaluated from the 1H NMR spectra by integration of the alkene and
epoxide signals. c ee was determined using CSP HPLC using a
Chiralcel OD-H column unless otherwise indicated. d Absolute
configurations of the major enantiomers were determined by
comparison of optical rotation with those reported in the literature.
e ee was determined using CSP GC using a Chiraldex B-DM column.
f ee was determined using 1H NMR spectroscopy in the presence
of europium(III) tris[3-(heptafluoropropylhydroxymethylene)-
(+)-camphorate] as chiral shift reagent.
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water (2 × 100 mL per g of iminium salt) and brine (2 ×
100 mL per g of iminium salt). The organic fraction was dried
over MgSO4, and evaporated to dryness under reduced
pressure to yield the desired methyl azepines.
General procedure for the synthesis of iminium salts from the
corresponding azepines
The azepine substrate was dissolved in CH2Cl2 (30 mL per g of
azepine), and NBS (1.1 equiv.) added. The resulting bright
yellow solution was stirred for 30 min at room temperature,
after which time the solvent was switched to EtOH. To the
ethanolic solution was added NaBPh4 (1.1 equiv.) in the
minimum amount of MeCN with stirring, which caused the
iminium salt to precipitate. The solvent was switched to
CH2Cl2 and the solution transferred to a separating funnel.
The organic layer was washed with water (2 × 60 mL per g of
azepine) and brine (30 mL per g of azepine). The crude
product isolated after the removal of solvents was recrystallized
from EtOH. The crystalline product was filtered oﬀ and
washed with cold EtOH followed by Et2O and hexane. The iso-
lated iminium salt was left to dry under reduced pressure in
an oven at 60 °C overnight.
6,6′-Dimethylbiphenyl-2,2′-bis(carboxylic acid) (±)-8 .4 NaNO2
(7.8 g, 0.11 mol) was added in one portion to an ice cold solu-
tion of 2-amino-3-methylbenzoic acid (17.0 g, 0.11 mol) in
2.45 M NaOH (60 mL). The mixture was stirred at 0 °C until it
became homogeneous. An ice-cooled 4 M aqueous solution of
HCl (240 mL) was added to the solution at a rate such that the
temperature remained below 5 °C. The resulting orange solu-
tion of the diazonium salt was stirred at 0 °C for 20 min.
Cu2SO4·5H2O (24.0 g, 96 mmol) and water (75 mL) were
added, and the resulting solution cooled in an ice-bath. When
the solution had reached 5 °C, 30% w/v NH4OH solution
(47.5 mL) was added in one portion. A freshly prepared solu-
tion of NH2OH, prepared from treatment of (NH2OH)·H2SO4
(8.8 g, 53.5 mmol) with a 3 M ice-cold aqueous solution of
NaOH (38 mL, 0.11 mol), was added to the resulting deep-blue
solution. The solution was stirred for 20 min to cool to 0 °C.
The diazonium salt prepared above was added to the copper
solution in three equal portions of 50 mL. The temperature
was maintained below 7 °C throughout the procedure. After
the addition was complete, the resulting orange/red solution
was heated under reflux for 30 min, and allowed to cool. After
the red solution had attained ambient temperature, conc. HCl
(37.5 mL) was added slowly and the mixture was allowed to
stand overnight to provide for the complete precipitation of
the product. The yellow/brown precipitate was removed by fil-
tration using a Büchner funnel, washed with water and air-
dried. The crude material was stirred in boiling EtOH
(200 mL); any remaining bright yellow solid was removed by
filtration, leaving a clear brown filtrate. Crystallization of the
bis(carboxylic acid) (±)-8 was induced by the addition of water
to the filtrate to yield light brown crystals (8.4 g, 55%);
m.p. 226–230 °C (dec.); νmax(neat)/cm
−1 2982, 2907, 2667,
2579, 1680, 1583, 1436, 1377, 1316, 1159, 962, 799, 768, 722;
δH (500 MHz; d6-DMSO) 1.81 (6 H, s), 7.31 (2 H, t, J = 7.5 Hz),
7.44 (2 H, d, J = 7.5 Hz), 7.71 (2 H, d, J = 7.5 Hz), 12.28 (2 H,
broad); δC (125 MHz; d6-DMSO) 19.8, 126.6, 127.3, 132.9,
136.0, 140.7, 168.1.
6,6′-Dimethyl-2,2′-bis(hydroxymethyl)biphenyl (±)-9 .4
Compound (±)-8 (2.20 g, 8.2 mmol) was dissolved in Et2O
(30 mL) under a nitrogen atmosphere. The resulting pale
yellow solution was cooled to 0 °C, and LiAlH4 (0.93 g,
24.5 mmol) added slowly at a rate that just maintained the
eﬀervescence. The resulting suspension was heated under
reflux for 1 h, after which time the reaction mixture was
allowed to cool to room temperature. Solid Na2SO4 (6.0 g) was
added to the suspension, which was cooled in an ice-bath and
stirred for 5 min. Water (10 mL) was added dropwise to
quench the excess LiAlH4. The mixture was stirred for 30 min,
filtered through a layered pad of Celite and Na2SO4, and the
colourless filtrate concentrated under reduced pressure to
yield (±)-9 as a colourless crystalline solid (1.91 g, 96%);
νmax(neat)/cm
−1 3254, 3064, 3017, 2935, 2880, 1679, 1592,
1458, 1378, 1239, 1211, 1163, 1028, 994, 902, 783, 760, 623; δH
(500 MHz; CDCl3) 1.86 (6 H, s), 3.19 (2 H, s), 4.08 (2 H, d, J =
11.5 Hz), 4.24 (2 H, d, J = 11.5 Hz), 7.24 (2 H, s, J = 7.5 Hz),
7.29 (2 H, t, J = 7.5 Hz), 7.34 (2 H, d, J = 7.5 Hz); δC (125 MHz;
CDCl3) 20.2, 63.1, 127.6, 128.0, 129.9, 136.1, 138.3, 138.5; m/z
(HNES) found for [C16H18O2 + Na]
+ 265.1200; [M + Na]+
requires 265.1199.
6,6′-Dimethyl-1,1′-biphenyl-2,2′-bis(carboxaldehyde) (±)-7 .29
PCC (1.33 g, 62.0 mmol) was added in one portion to a solu-
tion of (±)-9 (0.50 g, 20.7 mmol) in CH2Cl2 (20 mL), producing
a dark-orange solution. The solution was stirred vigorously for
3 h at room temperature. Et2O (20 mL) and a spatula of Celite
was added to the resulting black mixture, which was stirred for
a further 30 min. The reaction mixture was filtered through a
layered pad of Celite and silica gel. Solvents were removed
under reduced pressure to yield compound (±)-7 as a colour-
less crystalline solid (0.43 g, 87%); m.p. 108–110 °C;
δH (500 MHz; CDCl3) 1.98 (6 H, s), 7.50 (2 H, t, J = 7.5 Hz), 7.59
(2 H, d, J = 7.5 Hz), 7.91 (2 H, d, J = 7.5 Hz), 9.60 (2 H, s);
δC (125 MHz; CDCl3) 19.7, 126.4, 128.6, 134.5, 135.9, 137.6,
140.0, 191.4; m/z (HNES) found for [C16H14O2 + NH4]
+:
256.1333; [M + NH4]
+ requires 256.1332.
(+)-(R)-6-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,11-
dimethyl-6,7-dihydro-5H-dibenzo[c,e]azepine 10Rax and (+)-(S)-
6-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,11-dimethyl-
6,7-dihydro-5H-dibenzo[c,e]azepine 10Sax. Amine 4 (2.70 g,
12.9 mmol) was added to a solution of (±)-7 (2.81 g,
11.8 mmol) in MeOH (160 mL). After stirring for 5 min,
NaBH3CN (1.62 g, 25.8 mmol) and glacial acetic acid (1 mL)
were added. The solution was stirred for 24 h at room tempera-
ture. A 1 M aqueous solution of NaOH (20 mL) was added, fol-
lowed by Et2O (100 mL). The organic layer was collected, and
the aqueous layer extracted with Et2O (2 × 30 mL). The organic
fractions were combined, washed with brine, and dried over
Na2SO4. The solvents were removed under reduced pressure to
yield a crude oil that was purified by flash column chromato-
graphy, eluting with light petroleum/EtOAc (10 : 1), buﬀered
with 2% TEA, to give the desired compound as a mixture of
Organic & Biomolecular Chemistry Paper
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diastereoisomers [First eluting 10Rax as a colourless crystalline
solid (1.18 g, 49%); and second eluting 10Sax as a colourless
foam (0.62 g, 26%)].
First eluting amine 10Rax: [α]D +54.9 (c = 0.97, CDCl3);
νmax(neat)/cm
−1 2990, 2934, 2860, 1452, 1378, 1308, 1263,
1236, 1200, 1172, 1150, 1075, 1027 953, 852, 787, 749, 727,
698; δH (400 MHz; CDCl3) 1.58 (3 H, s), 1.64 (3 H, s), 2.11 (6 H,
s), 2.65 (1 H, d, J = 1.9 Hz), 3.16 (2 H, d, J = 12.1 Hz), 3.67 (2 H,
d, J = 12.1 Hz), 4.12–4.21 (2 H, m), 5.10 (1 H, d, J = 3.1 Hz),
6.98–7.02 (2 H, m), 7.14–7.18 (4 H, m), 7.24–7.36 (5 H, m);
δC (100 MHz; CDCl3) 19.3, 20.0, 29.9, 53.2, 60.1, 61.9, 75.3,
99.3, 126.4, 126.7, 126.9, 127.5, 127.8, 129.0, 135.4, 136.7,
138.6, 140.5; m/z found for [C28H31NO2 + H]
+ 414.2431;
[M + H]+ requires 414.2428.
Second eluting amine 10Sax: [α]D +121.0 (c = 1.07, CDCl3);
νmax(neat)/cm
−1 2990, 2939, 2859, 1497, 1452, 1378, 1332,
1263, 1236, 1198, 1168, 1140, 1076 1024, 1001, 952, 853, 787,
750, 722, 697, 665; δH (400 MHz; CDCl3) 1.46 (3 H, s), 1.49 (3
H, s), 2.12 (6 H, s), 3.01 (1 H, br), 3.31 (2 H, d, J = 12.5 Hz),
3.46 (2 H, d, J = 12.4 Hz), 3.92 (1 H, d, J = 12.4 Hz), 4.13 (1 H,
d, J = 12.4 Hz), 5.13 (1 H, d, J = 3.0 Hz), 6.80–7.02 (2 H, m),
7.16–7.27 (4 H, m), 7.33 (2 H, t, J = 7.6 Hz), 7.45 (2 H, d, J = 7.6
Hz); m/z found for [C28H31NO2 + H]
+: 414.2425; [M + H]+
requires 414.2428.
(−)-(Ra)-6-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-1,11-
dimethyl-5H-dibenzo[c,e]azepin-6-ium tetraphenylborate 5Rax.
Prepared according to the general procedure from 10Rax
(1.10 g, 2.66 mmol). The title compound 5Rax was isolated as a
fine yellow powder (1.18 g, 61%). [α]20D −190.5 (c = 1.01, MeCN);
νmax(neat)/cm
−1 3055, 3002, 2161, 2041, 1976, 1629, 1580,
1478, 1450, 1426, 1382, 1350, 1263, 1238, 1202, 1164, 1107,
1031, 955, 847, 790, 730, 664, 611; δH (400 MHz; DMSO-d6)
1.70 (3 H, s), 1.71 (3 H, s), 1.94 (3 H, s), 2.18 (3 H, s), 3.96 (1 H,
d, J = 12.7 Hz), 4.17 (1 H, d, J = 13.7 Hz), 4.53 (1 H, s), 4.62
(1 H, dd, J = 13.7 Hz, 2.9 Hz), 5.55 (1 H, br, ArCH̲2N), 5.82 (1 H,
d, J = 2.5 Hz), 6.79 (4 H, t, J = 7.1 Hz), 6.92 (8 H, t, J = 7.3 Hz),
7.10–7.29 (14 H, m), 7.36 (1 H, d, J = 7.9 Hz), 7.41–7.48 (2 H, m),
7.53 (1 H, t, J = 7.8 Hz), 7.71 (1 H, d, J = 7.6 Hz), 8.92 (1 H, s); δC
(100 MHz; DMSO-d6) 19.3, 20.2, 29.9, 56.2, 61.2, 66.5, 71.3,
100.8, 122.2, 125.5, 125.8, 125.9, 128.37, 128.38, 128.42, 129.1,
129.7, 132.2, 136.2, 137.1, 138.3, 139.0, 139.9, 164.0; m/z found
for [C28H30NO2]
+ 412.2273, iminium cation requires 412.2271.
(+)-(Sa)-6-((4S,5S)-2,2-Dimethyl-4-phenyl-[1,3]dioxan-5-yl)-1,11-
dimethyl-5H-dibenzo[c,e] azepinium tetraphenylborate 5Sax.
Prepared according to the general procedure from 10Sax
(0.56 g, 1.35 mmol). The title compound 5Sax was isolated as a
yellow solid (0.83 g, 83%). [α]20D +329.8 (c = 0.98, MeCN);
νmax(neat)/cm
−1 3059, 2989, 2161, 1977, 1623, 1578, 1559,
1427, 1381, 1359, 1308, 1263, 1239, 1168, 1122, 1086, 1069,
1031, 1000, 969, 43, 783, 728, 664, 608; δH (400 MHz; DMSO-
d6) 1.72 (3 H, s), 1.75 (3 H, s), 2.03 (3 H, s), 2.23 (3 H, s), 3.83
(1 H, d, J = 13.2 Hz), 4.19 (1 H, d, J = 13.7 Hz), 4.70 (1 H, dd, J =
13.8 Hz, 3.9 Hz), 4.83 (1 H, s), 4.97 (1 H, d, J = 13.5 Hz), 5.85
(1 H, d, J = 2.9 Hz), 6.84 (4 H, t, J = 7.2 Hz), 6.98 (8 H, t, J = 7.4
Hz), 7.10–7.19 (5 H, m), 7.21–7.29 (8 H, m), 7.42 (1 H, d, J = 8.0
Hz), 7.49 (1 H, t, J = 7.5 Hz), 7.55 (1 H, d, J = 8.0 Hz), 7.64 (1 H,
t, J = 7.7 Hz), 7.71–7.76 (2 H, m), 9.17 (1 H, s); δC (125 MHz;
acetone-d6) 17.9, 19.1, 19.2, 59.4, 62.1, 67.0, 71.4, 100.8, 121.3,
125.1 (q, J = 2.8 Hz), 125.5, 126.1, 128.1, 128.3, 128.68, 128.74,
129.0, 130.6, 132.1, 134.2, 136.1, 136.2 (q, J = 1.3 Hz), 137.16,
137.18, 138.4, 139.3, 140.2, 163.5, 163.9, 164.3, 164.7, 171.2;
m/z found for [C28H30NO2]
+ 412.2268; iminium cation requires
412.2271.
(5R,11bRa)-6-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-
1,5,11-trimethyl-6,7-dihydro-5H-dibenzo[c,e]azepine 11Rax.
Prepared according to the general procedure from 5Rax (0.60 g,
1.45 mmol). The title compound 11Rax was isolated as a col-
ourless foam (0.34 g, 94%). νmax(neat)/cm
−1 3059, 2991, 2921,
2859, 1593, 1497, 1452, 1378, 1342, 1265, 1239, 1201, 1156,
1079, 1029, 955, 910, 885, 853, 787, 744, 700; δH (400 MHz;
CDCl3) 0.21 (3 H, d, J = 7.2 Hz), 1.56 (3 H, s), 1.63 (3 H, s), 2.07
(3 H, s), 2.13 (3 H, s), 2.91 (1 H, dd, J = 6.0 Hz, 3.9 Hz), 3.35
(1 H, d, J = 11.4 Hz), 3.52 (1 H, d, J = 11.4 Hz), 4.08 (1 H, dd, J =
12.3 Hz, 2.1 Hz), 4.22 (1 H, dd, J = 12.0 Hz, 4.0 Hz), 4.33 (1 H,
q, J = 7.0 Hz), 5.15 (1 H, d, J = 3.5 Hz), 6.81 (1 H, t, J = 4.4 Hz),
6.86 (1 H, dd, J = 6.7 Hz, 2.0 Hz), 7.09–7.15 (4 H, m), 7.20–7.38
(5 H, m); δC (100 MHz; CDCl3) 19.2, 19.3, 19.4, 21.0, 29.1, 54.0,
59.7, 60.0, 63.2, 74.2, 99.3, 126.0, 126.4, 126.6, 126.8, 127.4,
127.6, 128.5, 128.7, 135.9, 136.9, 138.9, 139.2, 140.3, 141.3; m/z
(HNES) found for [C29H33NO2 + H]
+ 428.2582; [M + H]+
requires 428.2584.
(5S,11bSa)-6-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-
1,5,11-trimethyl-6,7-dihydro-5H-dibenzo[c,e]azepine 11Sax.
Prepared according to the general procedure from 5Sax (0.40 g,
0.97 mmol). The title compound 11Sax was isolated as a col-
ourless foam (0.23 g, 99%). νmax(neat)/cm
−1 3059, 2991, 2921,
2859, 1593, 1497, 1452, 1378, 1342, 1265, 1239, 1201, 1156,
1079, 1029, 955, 910, 885, 853, 787, 744, 700; δH (400 MHz;
CDCl3) 0.14 (3 H, d), 1.47 (3 H, s), 1.50 (3 H, s), 2.05 (3 H, s),
2.14 (3 H, s), 3.02 (1 H, dd, J = 6.5 Hz, 4.1 Hz), 3.31 (1 H, d, J =
11.3 Hz), 3.63 (1 H, q, J = 7.1 Hz), 3.90 (1 H, d, J = 11.3 Hz),
4.01 (1 H, dd, J = 12.3 Hz, 2.4 Hz), 4.15 (1 H, dd, J = 12.3 Hz,
4.0 Hz), 5.20 (1 H, d, J = 4.2 Hz), 6.65–6.71 (1 H, m), 6.95 (1 H,
dd, J = 6.6 Hz, 2.1 Hz), 7.02–7.07 (2 H, m), 7.15–7.24 (3 H, m),
7.32 (2 H, t, J = 7.7 Hz), 7.46 (2 H, t, J = 7.1 Hz); δC (125 MHz;
chloroform-d ) 19.4, 19.5, 19.6, 22.3, 29.0, 50.9, 62.2, 63.1, 67.0,
73.7, 99.0, 126.0, 126.5, 126.57, 126.63, 127.2, 127.4, 127.6,
128.5, 128.9, 135.4, 136.3, 136.6, 138.1, 138.9, 140.0, 140.8; m/z
(HNES) found for [C29H33NO2 + H]
+: 428.2579; [M + H]+
requires 428.2584.
(−)-(5R,11bRa)-6-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-
yl)-1,5,11-trimethyl-5H-dibenzo[c,e]azepin-6-ium tetraphenyl-
borate 6Rax. Prepared according to the general procedure from
11Rax (0.34 g, 0.81 mmol). The title compound 6Rax was iso-
lated as a yellow powder (0.18 g, 30%). [α]20D −167.2 (c = 1.00,
MeCN); νMAX(neat)/cm
−1 3053, 2986, 1632, 1579, 1559, 1540,
1478, 1425, 1379, 1298, 1262, 1239, 1201, 1165, 1107, 1085,
1045, 1032; δH (400 MHz; DMSO) 0.78 (3 H, br), 1.68 (3 H, s),
1.70 (3 H, s), 1.90 (3 H, s), 2.16 (3 H, s), 4.26 (1 H, d, J = 13.2
Hz), 4.63–4.68 (2 H, m), 5.76 (1 H, br), 5.82 (1 H, s), 6.79 (4 H,
t, J = 7.2 Hz), 6.92 (8 H, t, J = 7.4 Hz), 7.10–7.25 (14 H, m),
7.32–7.40 (2 H, m), 7.59 (1 H, br), 7.71–7.74 (1 H, m), 9.20
Paper Organic & Biomolecular Chemistry
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(1 H, s); δC (100 MHz; DMSO) 14.9, 19.3, 19.9, 20.0, 29.9, 62.0,
65.9, 67.4, 70.8, 101.0, 122.2, 125.2, 125.9, 126.5, 127.5, 128.3,
128.7, 128.8, 129.7, 131.1, 132.0, 132.1, 136.2, 136.4, 137.7,
138.8, 139.2, 140.2, 164.0; m/z found for [C29H32NO2]
+:
426.2435, iminium cation requires 426.2428.
(+)-(5S,11bSa)-6-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-
yl)-1,5,11-trimethyl-5H-dibenzo[c,e]azepin-6-ium tetraphenyl-
borate 6Sax. Prepared according to the general procedure from
11Sax (0.25 g, 0.58 mmol). The title compound 6Sax was iso-
lated as a pale yellow powder (0.14 g, 32%). [α]20D +310.0 (c =
1.00, MeCN); νmax(neat)/cm
−1 3055, 2999, 1625, 1580, 1562,
1478, 1452, 1427, 1383, 1306, 1262, 1202, 1166, 1112, 1085,
1032, 952, 844, 789, 748, 734, 666, 611; δH (400 MHz; DMSO)
0.65 (3 H, d, J = 7.2 Hz), 1.67 (6 H, s), 1.96 (3 H, s), 2.13 (3 H,
s), 4.15 (1 H, d, J = 14.3 Hz), 4.65–4.69 (2 H, m), 5.76 (1 H, q,
J = 7.3 Hz), 5.85 (1 H, s), 6.79 (4 H, t, J = 7.2 Hz), 6.92 (8 H, t,
J = 7.4 Hz), 7.04–7.22 (13 H, m), 7.38 (1 H, J = 7.4 Hz),
7.42–7.52 (2 H, m), 7.59 (1 H, t, J = 7.7 Hz), 7.72 (2 H, t, J = 7.7
Hz), 8.98 (1 H, s); δC (100 MHz; d6-DMSO) 14.4, 19.3, 19.9,
20.0, 30.0, 61.6, 68.1, 68.4, 71.8, 101.0, 122.2, 125.9, 126.0,
127.65, 127.70, 128.4, 128.6, 128.9, 129.5, 132.1, 132.3, 132.5,
136.17, 136.18, 136.5, 137.9, 139.0, 139.3, 140.1, 141.1, 164.0,
170.7; m/z found for [C29H32NO2]
+ 426.2424; iminium cation
requires 426.2428.
(−)-(Ra)-5,5′,6,6′,7,7′,8,8′-Octahydro-1,1′-binaphthyl-2,2′-diol
13 .29 (Ra)-Binol (3.00 g, 11.5 mmol) was divided equally
between three test tubes each containing Pd/C 10% w/w
(0.20 g). Glacial acetic acid (4.0 mL) was added to each of the
test tubes and mixed. The tubes were then placed in a hydro-
genation apparatus, and were charged and evacuated with H2
twice. The pressure was increased to 50 bar and the reaction
mixtures stirred at ambient temperature. The reactions were
monitored over 10 days. The combined mixture was filtered
through celite and washed through with CHCl3. The organic
filtrate was washed with saturated aqueous NaHCO3 (1 ×
50 mL), water (2 × 50 mL), and brine (1 × 50 mL). The organic
layer was dried over MgSO4 and solvents were removed under
reduced pressure to yield a colourless solid. Column chromato-
graphy was performed, eluting with light petroleum ether/
EtOAc (4 : 1), to yield compound 13 as a colourless solid which
was crystallized from hexane to give fine colourless needles
(1.63 g, 52%); [α]20D −42.6 (c = 1.06, CHCl3), lit.29 [α]20D −42.5 (c =
1.00, CHCl3); νmax(neat)/cm
−1 3475, 3381, 2929, 2856, 1587,
1472, 1333, 1287, 1248, 1195, 1152, 936, 828, 812, 726;
δH (300 MHz; CDCl3) 1.63–1.78 (8 H, m), 2.16 (2 H, dt, J = 17.0
Hz, 6.0 Hz), 2.29 (2 H, dt, J = 17.0 Hz, 6.1 Hz), 2.75 (4 H, t, J =
6.2 Hz), 4.56 (2 H, br), 6.83 (2 H, d, J = 8.4 Hz), 7.07 (2 H, d, J =
8.3 Hz); δC (75 MHz; CDCl3) 22.8, 22.9, 27.0, 29.1, 113.0, 118.8,
130.2, 131.1, 137.2, 151.5.
(−)-(Ra)-2,2′-Trifluoromethanesulfonyloxy-5,5′6,6′7,7′,8,8′-octa-
hydro-1,1′-binaphthyl 14 .28 Compound 13 (10.0 g, 34 mmol)
was dissolved in CH2Cl2 (250 mL) in a flame-dried flask under
an atmosphere of N2. The vessel was cooled to −30 °C. DMAP
(1.66 g, 13.6 mmol), 2,6-lutidine (11.9 mL, 102 mmol) and
Tf2O (17.2 mL, 102 mmol) were added to the solution and the
mixture stirred for 10 min, and allowed to reach room tem-
perature overnight. Silica gel was added to the dark brown
solution, and the mixture stirred for 20 min. The solvents were
removed under reduced pressure. The residue was transferred
to a sintered glass funnel containing a layer of silica gel and
washed with hexane until the product had eluted. The solvent
was removed under reduced pressure to yield compound 14 as
a colourless crystalline solid (28.01 g, 99%); m.p. 119–121 °C;
[α]20D −259.6 (c = 1.03, CHCl3), lit.28 [α]20D −260.3 (c = 1.00,
CHCl3); νmax(neat)/cm
−1; 2947, 2870, 2836, 1476, 1464, 1451,
1410, 1249, 1202, 1182, 1138, 1048, 926, 872, 926, 872, 853,
834, 806, 763, 699, 644; δH (300 MHz; CDCl3) 1.75 (8 H, m),
2.28 (2 H, dt, J = 6.0 Hz, 17.4 Hz), 2.43 (2 H, dt, J = 6.0, 17.7
Hz), 2.86 (4 H, t, J = 6.0 Hz), 7.16 (2 H, d, J = 8.6 Hz), 7.23 (2 H,
d, J = 8.6 Hz); δC (75 MHz; CDCl3) 22.2, 22.3, 27.4, 29.3, 118.1,
118.2 (q, J = 322 Hz), 127.1, 130.9, 138.3, 139.3, 144.8.
(−)-(Ra)-5,5′,6,6′,7,7′,8,8′-Octahydro-1,1′-binaphthyl-2,2′-bis-
(carboxylate) 15 .28 DMSO (90 mL), MeOH (36.0 mL, 1.56 mol)
and Hünig’s base (13.4 mL, 137 mmol) were added to 14
(1.50 g, 17.9 mmol), Pd(OAc)2 (0.61 g, 4.7 mmol) and dppp
(1.11 g, 4.70 mmol) under an argon atmosphere. The vessel
was sealed with a gas manifold and pressurised with CO (g) at
2 bar followed by evacuation of the atmosphere until the
orange solution just began to boil. The cycle was repeated five
times. During the cycles, the solution turned to opaque black.
The vessel was heated to 80 °C and maintained at a pressure
of 2.4 atm. of CO for 48 h. The reaction mixture was trans-
ferred to a round-bottomed flask, and solvents were removed
under reduced pressure to yield an oily residue. This crude
residue was purified by column chromatography, eluting with
light petroleum/EtOAc (5 : 1). Compound 15 was obtained as a
colourless crystalline solid (5.9 g, 88%); m.p. = 99–105 °C;
[α]20D −2.1 (c = 0.96, CHCl3), lit.28 [α]20D −1.9 (c = 1.00, CHCl3);
νmax(neat)/cm
−1 2926, 2853, 1718, 1588, 1430, 1400, 1289,
1251, 1186, 1164, 1124, 1066, 1050, 878, 861, 832, 771, 749;
δH (300 MHz; CDCl3) 1.69 (8 H, m), 1.99 (2 H, dt, J = 5.9 Hz,
17.0 Hz), 2.18 (2 H, dt, J = 6.4 Hz, 17.2 Hz), 2.86 (4 H, m), 3.57
(6 H, s), 7.13 (2 H, d, J = 8.1 Hz), 7.76 (2 H, d, J = 8.1 Hz); δC
(75 MHz; CDCl3) 22.4, 23.0, 27.2, 30.2, 51.5, 126.6, 127.1,
128.0, 135.4, 141.7, 141.9, 167.6.
(−)-(Ra)-5,5′,6,6′,7,7′,8,8′-Octahydro-1,1′-binaphthyl-2,2′-
dimethanol 12 .21 A suspension of LiAlH4 (0.30 g, 7.94 mmol)
in Et2O (50 mL) under a nitrogen atmosphere was cooled to
0 °C. Compound 15 (1.50 g, 3.97 mmol) was added slowly.
After the eﬀervescence had ceased, the reaction mixture was
heated under reflux for 30 min. The mixture was cooled in an
ice bath. Na2SO4 (1.50 g) and Celite were added in one portion
and stirred for 10 min followed by the dropwise addition of
water (2.0 mL). After 30 min, the mixture was filtered through
a pad of Celite and Na2SO4, and washed though with Et2O.
The solvents were removed under reduced pressure to yield
compound 12 as a colourless foam (1.24 g, 99%); [α]20D −39.1
(c = 0.96, MeOH), lit.21 [α]20D −39.0 (c = 1.01, MeOH); νmax(neat)/
cm−1 3257, 2923, 2853, 1594, 1433, 1231, 1061, 1005, 899, 815,
740; δH (300 MHz; CDCl3) 1.69 (8 H, m), 2.02 (4 H, m), 2.82
(4 H, t, J = 8.8 Hz), 2.92 (2 H, s), 4.02 (2 H, d, J = 12.0 Hz), 4.21
(2 H, d, J = 12.0 Hz), 7.11 (2 H, d, J = 8.8 Hz), 7.24 (2 H, d, J =
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8.8 Hz); δC (75 MHz; CDCl3) 22.7, 23.2, 27.6, 29.8, 62.9, 127.2,
128.9, 134.8, 135.7, 137.6, 138.3.
(+)-(Ra)-5,5′,6,6′,7,7′,8,8′-Octahydro-1,1′-binaphthyl-2,2′-bis-
(carbaldehyde) 16 .21 Compound 12 (0.11 g, 0.34 mmol) was
dissolved in CH2Cl2 (20 mL), and PCC (0.22 g, 1.02 mmol)
added in one portion. The resulting dark orange solution was
stirred for 2 h, and celite added followed by Et2O (20 mL). The
mixture was stirred for 30 min and filtered through a layered
pad of silica gel and Celite. The desired compound was eluted
with Et2O. Solvents were then removed to furnish compound
16 as a colourless crystalline solid (0.11 g, 99%); m.p.
129–131 °C; [α]20D +110.4 (c = 0.83, CHCl3), lit.
21 [α]20D +108.5 (c =
1.00, CHCl3); νmax(neat)/cm
−1 2931, 2851, 2747, 1688, 1672,
1582, 1441, 1383, 1315, 1292, 1268, 1246, 1230, 1162, 1125,
996, 968, 943, 913, 897, 836, 811, 760; δH (300 MHz; CDCl3)
1.73 (8 H, m), 2.15 (4 H, m), 2.91 (4 H, t, J = 6.1 Hz), 7.29 (2 H,
d, J = 8.1 Hz), 7.82 (2 H, d, J = 8.1 Hz), 9.51 (2 H, s);
δC (75 MHz; CDCl3) 22.2, 22.7, 27.4, 30.4, 125.1, 129.8, 132.4,
136.2, 140.7, 145.2, 191.5.
(Ra)-5,5′,6,6′,7,7′,8,8′-Octahydro-1,1′-binaphthyl-2,2′-bis-
(bromomethyl) 18 .27 Compound 12 (2.03 g, 6.3 mmol) was
dissolved in toluene (60 mL) under an atmosphere of N2, and
pyridine (0.05 mL, 0.7 mmol) added. Tribromophosphine
(1.78 mL, 18.9 mmol) was added dropwise. After the addition
was complete, the mixture was heated at 60 °C for 3 h. After
cooling, water (50 mL) was added, and the resulting biphasic
mixture transferred to a separating funnel. The organic layer
was isolated and washed with saturated aqueous NaHCO3
(20 mL). The organic layers were dried over MgSO4 and de-
colourized with a spatula of carbon black, and filtered. The
solvents were removed under reduced pressure to yield com-
pound 18 as a colourless powder (2.79 g, 99%); [α]20D +34.3 (c =
2.05, CHCl3), lit.
27 [α]20D +36.5 (c = 1.00, CH2Cl2); νmax(neat)/
cm−1 2920, 2851, 1592, 1457, 1376, 1235, 1204, 928, 862, 831,
814, 759, 723, 623; δH (300 MHz; CDCl3) 1.71 (8 H, m), 2.07 (2
H, dt, J = 6.4 Hz, 17.6 Hz), 2.34 (2 H, dt, J = 5.5 Hz, 17.0 Hz),
2.83 (4 H, t, J = 5.9 Hz), 4.10 (2 H, d, J = 9.9 Hz), 4.15 (2 H, d,
J = 10.0 Hz), 7.14 (2 H, d, J = 7.9 Hz), 7.33 (2 H, d, J = 7.9 Hz);
δC (75 MHz; CDCl3) 22.6, 22.9, 27.5, 29.9, 32.9, 128.1, 129.6,
132.3, 135.6, 137.9, 138.6.
(−)-(Ra)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-
4,5,8,9,10,11,12,13,14,15-decahydro-3H-dinaphtho[2,1-c:1′,2′-e]-
azepine 17. Method 1: Compound 18 (0.17 g, 0.38 mmol) was
dissolved in MeCN (10 mL) under an atmosphere of N2. K2CO3
(0.15 g, 1.11 mmol) and a solution of amine 4 (79 mg,
0.38 mmol) in MeCN (2 mL) were added. The mixture was
stirred at room temperature for 1 h, heated under reflux over-
night, and allowed to cool. CH2Cl2 (30 mL) and water (30 mL)
were added. The organic layer was separated and the aqueous
layer washed with CH2Cl2 (2 × 20 mL). The organic layers were
combined and dried over MgSO4, and solvents were removed
under reduced pressure to yield 17 in excellent purity as col-
ourless crystals (0.18 g, 97%).
Method 2: Compound 16 (0.11 g, 0.35 mmol) was sus-
pended in MeOH (4 mL) under an atmosphere of N2. A solu-
tion of amine 4 (79 mg, 1.1 equiv., 0.38 mmol) in MeOH
(1 mL) was added followed by NaCNBH3 (44 mg, 2 equiv.,
0.70 mmol) and glacial acetic acid (0.2 mL). The mixture was
stirred for 24 h at ambient temperature, and a 1 M aq. solution
of NaOH (25 mL) added. The mixture was extracted with Et2O
(3 × 20 mL). The combined organic layers were washed with
brine (30 mL) and dried over MgSO4. Solvents were removed
under reduced pressure to yield a pale yellow foam that was
purified by column chromatography, eluting with light pet-
roleum ether/EtOAc (5 : 1). Compound 17 was isolated as col-
ourless crystals (116 mg, 67%). [α]20D −27.7 (c = 0.72, CHCl3);
νmax(neat)/cm
−1 2928, 2832, 1451, 1377, 1291, 1267, 1237,
1194, 1172, 1147, 1074, 1053, 1017, 939, 898, 852, 829, 810,
753, 723, 700, 654, 640, 628; δH (300 MHz; CDCl3) 1.46–1.57
(2 H, m), 1.57 (3 H, s), 1.62 (3 H, s), 1.67–1.82 (6 H, m), 2.13
(2 H, dt, J = 5.9 Hz, 11.5 Hz), 2.58–2.65 (3 H, m), 2.75–2.86
(4 H, m), 3.09 (2 H, d, J = 12.1 Hz), 3.57 (2 H, d, J = 12.2 Hz),
4.17 (2 H, m), 5.07 (1 H, d, J = 3.1 Hz), 6.89 (2 H, d, J = 7.6 Hz),
6.98 (2 H, d, J = 7.6 Hz), 7.30 (5 H, m); δC (75 MHz; CDCl3)
19.1, 22.7, 22.9, 27.6, 29.4, 29.6, 52.7, 59.8, 61.8, 75.0, 99.1,
126.0, 126.7, 127.6, 128.2, 133.6, 135.0, 136.0, 138.2, 140.4; m/z
(HNES) found for [C34H39NO2 + H]
+: 494.3039; [M + H]+:
requires 494.3039.
(−)-(Ra)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-
8,9,10,11,12,13,14,15-octahydro-3H-dinaphtho[2,1-c:1′,2′-e]-
azepin-4-ium tetraphenylborate 19. Prepared according to the
general procedure from 17 (1.47 g, 2.98 mmol) and NBS
(0.58 g, 3.28 mmol). Ion exchange was performed with NaBPh4
(1.12 g, 3.28 mmol). The title compound 19 was isolated as a
fine, pale-yellow crystalline solid (1.51 g, 63%). m.p.
195–199 °C; [α]20D −331.9 (c = 1.01, acetone); νmax(neat)/cm−1
3053, 2982, 2936, 2864, 1615, 1577, 1479, 1450, 1424, 1380,
1304, 1263, 1235, 1198, 1107, 1083, 1010, 954, 941, 904, 835,
763, 746, 731, 701, 660, 623, 609; δH (400 MHz; acetone-d6,
50 °C) 1.35–1.41 (1 H, m), 1.45–1.56 (1 H, m), 1.67 (3 H, s),
1.70 (3 H, s), 1.67–1.85 (6 H, m), 2.01–2.06 (1 H, m), 2.24 (1 H,
J = 7.5 Hz), 2.53–2.62 (1 H, m), 2.70–3.01 (5 H, m), 4.12 (1 H, d,
J = 13.2 Hz), 4.21 (2 H, d, J = 13.7 Hz), 4.41 (1 H, t, J = 2.6 Hz),
4.63 (1 H, dd, J = 13.7 Hz, 3.0 Hz), 5.18 (1 H, d, J = 13.7 Hz),
5.74 (1 H, d, J = 3.0 Hz), 6.75 (4 H, t, J = 7.2 Hz), 6.89 (8 H, t, J =
7.4 Hz), 7.06–7.21 (6 H, m), 7.23–7.40 (11 H, m), 8.73 (1 H, s);
δC (75 MHz; acetone-d6) 18.0, 21.6, 21.9, 22.0, 22.1, 27.4, 27.5,
28.9, 29.2, 29.8, 57.6, 60.1, 66.0, 71.3, 100.8, 121.6, 124.9,
125.0, 125.3, 125.8, 128.1, 128.8, 129.1, 129.4, 130.4, 133.5,
134.5, 136.28, 136.32, 137.7, 139.1, 139.9, 140.9, 145.0, 164.3,
169.7; m/z (HNES) found for [C34H38NO2]
+: 492.2895; iminium
cation requires 492.2897.
(−)-(3R,11cRa)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-
yl)-3-methyl-4,5,8,9,10,11,12,13,14,15-decahydro-3H-dinaphtho
[2,1-c:1′,2′-e]azepine 20. Prepared according to the general pro-
cedure from 19 (1.28 g, 1.57 mmol) and 3 M MeMgBr
(5.26 mL, 15.7 mmol). The crude mixture was purified by
column chromatography eluting with light petroleum/EtOAc
(5 : 1), buﬀered with 2% TEA. The title compound 20 was iso-
lated as a colourless oil (0.63 g, 79%). [α]20D −8.4 (c = 2.04,
CHCl3); δH (300 MHz; CDCl3) 0.18 (3 H, d, J = 7.1 Hz),
1.42–1.63 (2 H, m), 1.55 (3 H, s), 1.63 (3 H, s), 1.68–1.81 (6 H,
Paper Organic & Biomolecular Chemistry
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m), 2.09–2.19 (2 H, m), 2.54–2.69 (2 H, m), 2.77–2.82 (4 H, m),
2.91 (1 H, td, J = 4.2 Hz, 2.5 Hz), 3.31 (1 H, d, J = 11.2 Hz), 3.35
(1 H, d, J = 11.2 Hz), 4.09 (1 H, dd, J = 12.3 Hz, 2.4 Hz), 4.21
(1 H, dd, J = 12.3 Hz, 4.3 Hz), 4.34 (1 H, q, J = 7.0 Hz), 5.13
(1 H, d, J = 3.5 Hz), 6.81 (1 H, d, J = 7.6 Hz), 6.81 (1 H, d, J = 7.7
Hz), 6.94 (1 H, d, J = 7.6 Hz), 6.97 (1 H, d, J = 7.7 Hz), 7.22–7.38
(1 H, m); δC (75 MHz; CDCl3) 19.4, 21.0, 22.7, 22.8, 22.9, 27.3,
29.0, 29.3, 29.4, 54.3, 59.0, 60.1, 62.9, 74.1, 99.3, 125.9, 126.4,
126.5, 126.6, 127.6, 128.1, 128.2, 135.2, 135.5, 135.6, 135.7,
136.1, 136.6, 138.4, 138.8, 140.3; m/z (HNES) found for
[C35H41NO2 + H]
+: 508.3204; [M + H]+ requires 508.3210.
(−)-(3R,11cRa)-4-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-
yl)-3-methyl-8,9,10,11,12,13,14,15-octahydro-3H-dinaphtho-
[2,1-c:1′,2′-e]azepin-4-ium tetraphenylborate 21. Prepared
according to the general procedure from 20 (0.62 g,
1.22 mmol) and NBS (0.24 g, 1.34 mmol). Ion exchange was
performed using NaBPh4 (0.46 g, 1.34 mmol). The title com-
pound 21 was isolated as a pale yellow crystalline solid (0.71 g,
71%). m.p. 121–122 °C; [α]20D −232.8 (c = 1.00, acetone);
νmax(neat)/cm
−1 3055, 2986, 2936, 2864, 1623, 1575, 1479,
1449, 1426, 1381, 1308, 1265, 1236, 1201, 1165, 1107, 1080,
1031, 1000, 956, 910, 835, 731; δH (400 MHz; acetone-d6) 1.05
(3 H, d, J = 7.1 Hz), 1.35–1.58 (2 H, m), 1.66–1.90 (6 H, m), 1.69
(3 H, s), 1.74 (3 H, s), 2.25 (1 H, dt, J = 10.4 Hz, 5.7 Hz),
2.47–2.60 (1 H, m), 2.72–2.88 (4 H, m), 2.98 (2 H, dd, J = 11.7
Hz, 6.5 Hz), 4.39 (1 H, dd, J = 0.8 Hz, 13.6 Hz), 4.74 (1 H, t, J =
2.5 Hz), 4.81 (1 H, dd, J = 13.7 Hz, 2.9 Hz), 5.49 (1 H, q, J =
6.5 Hz), 5.83 (1 H, d, J = 2.8 Hz), 6.78 (4 H, t, J = 7.1 Hz), 6.92
(8 H, t, J = 7.4 Hz), 7.02–7.23 (7 H, m), 7.28–7.37 (8 H, m), 7.44
(1 H, d, J = 8.0 Hz), 7.60 (1 H, d, J = 8.0 Hz), 9.25 (1 H, s);
δC (100 MHz; acetone-d6) 14.9, 18.1, 21.6, 22.1, 22.2, 22.4, 27.3,
27.6, 29.1, 29.3, 30.0, 61.9, 67.5, 69.8, 71.1, 101.0, 121.6, 124.8,
124.9, 125.3, 125.8, 128.0, 128.6, 129.2, 130.2, 130.5, 131.3,
136.0, 136.4, 138.1, 139.5, 139.7, 141.2, 147.7, 164.3, 168.6; m/z
(HNES) found for [C35H40NO2]
+: 506.3054; iminium cation
requires 506.3043.
General procedure for the formation of racemic epoxides
The alkene was dissolved in CH2Cl2 (10 mL per g of alkene)
and the solution cooled to 0 °C. A solution of m-CPBA
(2 equiv.) in CH2Cl2 (10 mL per g of alkene), dried over MgSO4,
was filtered into the solution of alkene. The reaction was allowed
to achieve ambient temperature and stirred until complete con-
version of the alkene was observed by TLC. Saturated aqueous
NaHCO3 (10 mL per g of alkene) was added, and organic layer
collected and washed with 1 M NaOH (10 mL per g of alkene),
and dried over MgSO4. The solvents were removed under reduced
pressure. Analytically pure samples of the epoxides were obtained
by means of flash column chromatography, typically eluting with
light petroleum/EtOAc (99 : 1), buﬀered with 2% TEA.
General procedures for catalytic asymmetric epoxidation of
alkenes with Oxone® mediated by iminium salts under
aqueous conditions
Method A: Oxone® (2 equiv.) and NaHCO3 (5 equiv.) were
added with stirring to a solution of the catalyst (5 mol%) in
MeCN (1 mL) and water (0.1 mL) at 0 °C. After 5 min, alkene
(3 mmol) dissolved in MeCN (1 mL), was added. The mixture
was stirred at 0 °C until complete conversion of the alkene was
observed by TLC, or for up to 6 h. The reaction mixture was
then diluted with Et2O (10 mL) and the resulting suspension
filtered through a pad of mixed Na2SO3 and MgSO4. The sol-
vents were removed under reduced pressure, and analytically
pure samples of the epoxide were obtained by means of flash
column chromatography or preparative TLC, typically eluting
with light petroleum/EtOAc (99 : 1), containing 2% TEA. The
major enantiomer was identified by [α]20D measurements and
comparison to the literature; enantioselectivities were deter-
mined either by chiral HPLC, or by 1H NMR spectroscopy in
the presence of a resolving agent.
Method B: A mixture of water (1 ml), MeCN (1 mL) and
NaHCO3 (100 mg, 1.2 mmol) was cooled in an ice-bath at 0 °C.
Oxone® (370 mg, 0.6 mmol) was added. After the eﬀervescence
had subsided, the catalyst (5 mol%) was added followed, after
1 min, by the alkene (0.3 mmol). The mixture was stirred at
0 °C until complete conversion of the alkene was observed by
TLC, or for up to 6 h. The reaction mixture was diluted with
Et2O (10 mL per 0.10 g of substrate), and the resulting suspen-
sion filtered through a pad of mixed Na2SO3 and MgSO4. The
solvents were removed under reduced pressure, and analyti-
cally pure samples of the epoxide were obtained by either flash
column chromatography or preparative TLC, eluting with light
petroleum/EtOAc (99 : 1), containing 2% TEA. The major enan-
tiomer was identified by [α]20D measurements and comparison
with the literature; enantioselectivities were determined either
by chiral HPLC, or by 1H NMR spectroscopy in the presence of
a resolving agent.
Method C: A mixture of water (0.8 mL) and NaHCO3
(67 mg, 0.80 mmol) was cooled in an ice-bath at 0 °C. Oxone®
(132.0 mg, 0.21 mmol) was added, and the solution stirred
until the eﬀervescence had ceased. The alkene (0.20 mmol)
was dissolved in CH2Cl2 (0.5 mL) and added. A solution of the
catalyst (5 mol%) and 18-crown-6 (1 mg, 2.5 mol%) in CH2Cl2
(0.7 mL) was cooled to 0 °C, and added with stirring. The reac-
tion mixture was vigorously stirred, typically for 2 h at 0 °C.
CH2Cl2 (10 mL) and water (10 mL), both cooled to around
0 °C, were added. The organic layer was collected and dried
over MgSO4. The solvents were removed under reduced
pressure, and analytically pure samples of the epoxide were
obtained by either column chromatography or preparative
TLC, eluting with light petroleum/EtOAc (99 : 1), containing
2% TEA. The major enantiomer was identified by
[α]20D measurements; enantioselectivities were determined
either by chiral HPLC, or by 1H NMR spectroscopy in the pres-
ence of a resolving agent.
Tetraphenylphosphonium monoperoxysulfate15
Tetraphenylphosphonium chloride (15.0 g, 40 mmol) was dis-
solved in CH2Cl2 (200 mL), and the solution cooled to 10 °C. A
solution of Oxone® (15.0 g, 48 mmol) in deionised water
(300 mL) was cooled to 10 °C, and added over a period of
5 min. The resulting biphasic mixture was stirred vigorously
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for 1 h. The organic layer was separated, and the solvents were
removed under reduced pressure at room temperature. The
crude colourless solid was washed with deionised water (3 ×
80 mL). The solid was re-dissolved in CH2Cl2 (150 mL) and
dried over MgSO4. Hexane was added until a solid precipitate
just began to form, and the flask placed in a freezer overnight.
The resulting colourless crystalline solid was collected by fil-
tration (12.87 g, 71%); νmax(neat)/cm
−1 3210, 3060, 1586, 1484,
1435, 1262, 1226, 1162, 1106, 1058, 1041, 996, 721;
δH (400 MHz; CDCl3) 7.58–7.69 (8 H, m), 7.71–7.80 (8 H, m),
7.82–7.86 (4 H, m), 9.18 (1 H, s). The oxygen content, typically
94% peroxide, was estimated by comparing the integrals of the
aromatic and hydroxyl signals.
General procedure for catalytic asymmetric epoxidation of
alkenes with TPPP mediated by iminium salts under
non-aqueous conditions
A solution of alkene was cooled to the required temperature,
and TPPP was added in one portion with stirring over 2 min.
The catalyst was added as a solid in small portions over 1 min.
The reaction was stirred until complete consumption of the
starting alkene had been observed, or until it was judged that
no further conversion was occurring, by TLC. Et2O, cooled to
0 °C, was added to precipitate out TPPP and its reduced by-pro-
ducts. The suspension was filtered through a thin pad of celite
and silica gel to yield the desired epoxide. If column chromato-
graphy was required, it was typically performed eluting with
light petroleum/EtOAc (99 : 1), containing 2% TEA. The major
enantiomer was identified by [α]20D measurements and com-
parison to the literature; enantioselectivities were determined
by either chiral HPLC, or by 1H NMR spectroscopy in the pres-
ence of a resolving agent.
(E)-Methylstilbene oxide.30 Isolated as a colourless crystal-
line solid: νmax(neat)/cm
−1 3061, 1601, 1495, 1449, 1370, 1278,
1156, 1117, 1065, 1026, 980; δH (300 MHz; CDCl3) 1.46 (3 H, s),
3.95 (1 H, s), 7.30–7.45 (10 H, m). HPLC conditions-hexane/2-
propanol (80 : 20), oven temp 20 °C, column Chiracel OD-H 01
250 × 4.6 mm, 5 μm particle size, flow rate 1 mL min−1,
254 nm: tr-4.00 min (−)-(1S,2S), 6.92 min (+)-(1R,2R).
1-Phenylcyclohexene oxide.30 Isolated as a colourless oil:
νmax(neat)/cm
−1 3083, 1602, 1495, 1445, 1359, 1248, 1174,
1133, 1078, 1030, 993, 974; δH (300 MHz; CDCl3) 1.20–1.33 (1 H,
m), 1.51–1.62 (3 H, m), 1.97–2.05 (2 H, m), 2.16–2.18 (1 H, m),
2.24–2.31 (1 H, m), 3.10 (1 H, t, J = 2.0 Hz), 7.26–7.41 (5 H, m).
1-Phenyldihydronaphthalene oxide.30 Isolated as a colour-
less crystalline solid: νmax(neat)/cm
−1 3087, 1601, 1493, 1284,
1176, 1158, 1094, 1072, 1028; δH (300 MHz; CDCl3) 2.10 (1 H,
td, J = 15.5 Hz, 5.6 Hz) 2.48–2.59 (1 H, m), 2.76 (1 H, dd, J =
15.5 Hz, 5.5 Hz) 2.96–3.07 (1 H, m), 3.70 (1 H, d, J = 3.0 Hz),
7.09–3.29 (4 H, m), 7.45–7.60 (5 H, m). HPLC conditions-
hexane/2-propanol (90 : 10), oven temp 20 °C, column Chiracel
OD-H 01 250 × 4.6 mm, 5 μm particle size, flow rate 1 mL
min−1, 254 nm: tr-4.51 min (−)-(1S,2R), 5.94 min (+)-(1R,2S).
(E)-Stilbene oxide.30 Isolated as a colourless crystalline
solid: νmax(neat)/cm
−1 3081, 1776, 1602, 1485, 1336, 1155,
1074, 1042, 953; δH (400 MHz; CDCl3) 3.87 (2 H, s), 7.29–7.39
(10 H, m); δC (75 MHz; CDCl3) 63.3, 126.0, 128.6, 129.3, 137.6.
HPLC conditions-hexane/2-propanol (80 : 20), oven temp 20 °C,
column Chiracel OD-H 01 250 × 4.6 mm, 5 μm particle size,
flow rate 1 mL min−1, 254 nm: tr-4.98 min (−)-(1S,2S),
6.54 min (+)-(1R,2R).
Dihydronaphthalene oxide.16 Isolated as a colourless oil:
νmax(neat)/cm
−1 3058, 3028, 2931, 2850, 1602, 1492, 1314,
1129, 1088, 1031, 965; δH (400 MHz; CDCl3) 1.65–1.84 (1 H, m),
2.33–2.42 (1 H, m), 2.52 (1 H, dd, J = 15.5 Hz, 5.5 Hz),
2.67–2.85 (1 H, m), 3.71–3.80 (1 H, m), 3.81–3.89 (1 H, m), 7.05
(1 H, d, J = 7.2 Hz), 7.18–7.35 (2 H, m), 7.40 (1 H, d, J = 7.1 Hz).
Triphenylethylene oxide.16 Isolated as a colourless crystal-
line solid: νmax(neat)/cm
−1 3061, 3031, 2956, 2924, 2857, 1604,
1595, 1498, 1471, 1448, 1262, 1220, 741, 699; δH (400 MHz;
CDCl3) 4.42 (1 H, s), 7.13–5.50 (15H, m). HPLC conditions-
hexane/2-propanol (90 : 10), oven temp 20 °C, column Chiracel
OD-H 01 250 × 4.6 mm, 5 μm particle size, flow rate 1 mL
min−1, 254 nm: tr – 4.26 min (+)-(S), 7.47 min (−)-(R).
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